| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/2011 | WO2011002258A9 Arginine-based amphiphilic peptide micelle |
| 07/07/2011 | WO2010151004A9 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids |
| 07/07/2011 | WO2010142620A3 Process for the preparation of colloidal systems for the delivery of active compounds |
| 07/07/2011 | WO2010132095A8 Method and composition to improve absorption of therapeutic agents |
| 07/07/2011 | WO2010109176A3 Parenteral pharmaceutical composition for use in gene therapy |
| 07/07/2011 | WO2010091078A3 Nanofabricated membrane using polymerized proteoliposomes |
| 07/07/2011 | WO2010089259A3 Sustained release composition containing quetiapine |
| 07/07/2011 | WO2010083360A3 Controlled-release formulations |
| 07/07/2011 | WO2010072419A3 Enema preparations and their use |
| 07/07/2011 | US20110166623 Implantable Retinal Electrode Array Configuration for Minimal Retinal Damage and Method of Reducing Retinal Stress |
| 07/07/2011 | US20110166432 Diagnostic interlabial pad |
| 07/07/2011 | US20110166417 Method and device for repair of degenerative cartilage |
| 07/07/2011 | US20110166218 Methods for micronization of hydrophobic drugs |
| 07/07/2011 | US20110166202 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/07/2011 | US20110166105 Antimicrobial wash and carrier solutions and uses thereof |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110165271 Antitumoral terpenoid pharmaceutical composition 'abisilin' exhibiting angiogenesis-inhibiting action |
| 07/07/2011 | US20110165260 Allantoin-containing skin cream |
| 07/07/2011 | US20110165259 Composite organic compound powder for medical use, method for producing same and suspension of same |
| 07/07/2011 | US20110165258 Polymeric delivery systems for active agents |
| 07/07/2011 | US20110165257 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165255 Malignant tumor heat therapy kit comprising anti-regulatory t cell antibody and magnetic fine particles and heat therapy method thereof |
| 07/07/2011 | US20110165254 Drug Delivery Using Fine Fiber Encapsulation |
| 07/07/2011 | US20110165253 Nicotine-containing granulate |
| 07/07/2011 | US20110165252 Memantine formulations |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165250 Compositions and methods for treatment of neoplastic disease |
| 07/07/2011 | US20110165249 Pharmaceutical solid preparation |
| 07/07/2011 | US20110165248 Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| 07/07/2011 | US20110165247 Device for the transdermal administration of a rotigotine base |
| 07/07/2011 | US20110165245 Compositions and methods for distraction osteogenesis |
| 07/07/2011 | US20110165244 Bioresponsive polymer formulations for delivery of bioactive agents |
| 07/07/2011 | US20110165243 Concurrent delivery of multiple therapeutic agents via hydrogels for biomedical applications |
| 07/07/2011 | US20110165242 In situ gelling drug delivery system |
| 07/07/2011 | US20110165241 Bazedoxifene formulations with antioxidants |
| 07/07/2011 | US20110165240 Galenical formulations of organic compounds |
| 07/07/2011 | US20110165239 Pharmaceutical compositions of atorvastatin |
| 07/07/2011 | US20110165238 Stabilized atypical antipsychotic formulation |
| 07/07/2011 | US20110165237 Protein Hydrolysate Excipients |
| 07/07/2011 | US20110165236 Controlled release hydrogel formulation |
| 07/07/2011 | US20110165235 Directly pressed aliskiren tablets |
| 07/07/2011 | US20110165234 Extended release venlafaxine formulation |
| 07/07/2011 | US20110165233 Stability additives for dry dha dosage forms |
| 07/07/2011 | US20110165232 Use of Opioid Antagonists for the Preparation of a Medicament in the Treatment of Retinal Degenerative Diseases |
| 07/07/2011 | US20110165231 Treatment of Fructose Malabsorption |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165229 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165227 Compositions and Methods Using siRNA Molecules for Treatment of Gliomas |
| 07/07/2011 | US20110165226 Influenza cap-leader sequence |
| 07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165223 Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen |
| 07/07/2011 | US20110165222 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 07/07/2011 | US20110165221 Wound care |
| 07/07/2011 | US20110165220 Drugs to prevent hpv infection |
| 07/07/2011 | US20110165219 Optimization of alginate encapsulation of islets for transplantation |
| 07/07/2011 | US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation |
| 07/07/2011 | US20110165205 Nanovector with positive charge substantive for hair and skin |
| 07/07/2011 | US20110165204 Gastric therapies and compositions therefor |
| 07/07/2011 | US20110165203 A topical composition comprising the isolated non-polar lipid fraction of lanolin4 |
| 07/07/2011 | US20110165202 Solid state forms of fosamprenavir calcium salt and processes for preparation thereof |
| 07/07/2011 | US20110165201 Anticancer formulation |
| 07/07/2011 | US20110165200 Novel hydrogels and uses thereof |
| 07/07/2011 | US20110165199 Composition and Process for Bone Growth and Repair |
| 07/07/2011 | US20110165198 Method for reducing lipid absorption by an animal |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165132 Heparan Sulphate Which Binds BMP2 |
| 07/07/2011 | US20110165097 Compositions for percutaneous administration |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165095 Composition and method for the inhibition of postoperative adhesions severity |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | US20110165092 Cosmetic and/or dermatological composition |
| 07/07/2011 | US20110165086 Iron oxide nanoparticles as mri contrast agents and their preparing method |
| 07/07/2011 | US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same |
| 07/07/2011 | US20110165068 Liposome medicament, method of preparation and use thereof |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110163472 Foamed sol-gel and method of manufacturing the same |
| 07/07/2011 | US20110163468 Device For Preparation of Liposomes and Method Thereof |
| 07/07/2011 | US20110162982 Methods for producing vaccine adjuvants |
| 07/07/2011 | CA2822435A1 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| 07/07/2011 | CA2786551A1 Systems and methods for anesthetizing ear tissue |
| 07/07/2011 | CA2785926A1 Injectable formulations for parenteral administration |
| 07/07/2011 | CA2785857A1 Production method of solid preparations and the solid preparations produced by the method |
| 07/07/2011 | CA2785639A1 Melt extruded nicotine thin strips |
| 07/07/2011 | CA2785638A1 Melt extruded thin strips containing coated pharmaceutical actives |
| 07/07/2011 | CA2785622A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/07/2011 | CA2785607A1 Administration route for a composition to protect an animal against rhodococcus equi |
| 07/07/2011 | CA2785263A1 Tape preparation |
| 07/07/2011 | CA2784530A1 Degradable removable implant for the sustained release of an active compound |
| 07/07/2011 | CA2784394A1 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
| 07/07/2011 | CA2784365A1 Low toxicity topical active agent delivery system |
| 07/07/2011 | CA2783715A1 Novel antibody formulation |
| 07/07/2011 | CA2783497A1 Porcine seminal material composition for artificial insemination of sows |
| 07/07/2011 | CA2773544A1 Core stabilized microcapsules, method of their preparation and uses thereof |
| 07/06/2011 | EP2341346A2 Methods of high-throughput screening for internalizing antibodies and metal-chelating liposomes |
| 07/06/2011 | EP2341072A2 Method for Generating Activated T-Cells and Antigen-Pulsed Antigen-Presenting Cells |
| 07/06/2011 | EP2340872A1 New pharmaceutical formulations useful in the treatment of insomnia |